Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.
Despite more than 25 years of research, the molecular targets of quinoline-3-carboxamides have been elusive although these compounds are currently in Phase II and III development for treatment of autoimmune/inflammatory diseases in humans. Using photoaffinity cross-linking of a radioactively labelle...
Guardado en:
Autores principales: | Per Björk, Anders Björk, Thomas Vogl, Martin Stenström, David Liberg, Anders Olsson, Johannes Roth, Fredrik Ivars, Tomas Leanderson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9b0cf5ec37a4cefa5970058e75fe613 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing
por: Hadar Reichman, et al.
Publicado: (2017) -
Sensor bias impact on efficient aeration control during diurnal load variations
por: Oscar Samuelsson, et al.
Publicado: (2021) -
TriQuinoline
por: Shinya Adachi, et al.
Publicado: (2019) -
Evaluation of the Apple iPhone 12 Pro LiDAR for an Application in Geosciences
por: Gregor Luetzenburg, et al.
Publicado: (2021) -
Characterization of the Fungitoxic Activity on <i>Botrytis cinerea</i> of <i>N</i>-phenyl-driman-9-carboxamides
por: Ricardo Melo, et al.
Publicado: (2021)